Total Payments
$5,306
2024 Payments
$723.99
Companies
32
Transactions
220
Medicare Patients
14,729
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$5,122 (96.5%)
Education$183.58 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,122 | 217 | 96.5% |
| Education | $183.58 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,225 | 51 | $0 (2024) |
| Astellas Pharma US Inc | $690.37 | 30 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $607.77 | 29 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $450.95 | 19 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $331.24 | 10 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $195.21 | 9 | $0 (2023) |
| Antares Pharma, Inc. | $177.42 | 8 | $0 (2024) |
| AbbVie, Inc. | $173.09 | 5 | $0 (2017) |
| UROVANT SCIENCES INC | $161.17 | 7 | $0 (2022) |
| PFIZER INC. | $153.62 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $723.99 | 35 | Sumitomo Pharma America, Inc. ($207.33) |
| 2023 | $1,073 | 40 | Sumitomo Pharma America, Inc. ($243.62) |
| 2022 | $807.60 | 36 | Janssen Biotech, Inc. ($225.81) |
| 2021 | $456.92 | 19 | Janssen Biotech, Inc. ($116.58) |
| 2020 | $185.92 | 6 | Astellas Pharma US Inc ($111.60) |
| 2019 | $740.79 | 33 | Janssen Biotech, Inc. ($196.57) |
| 2018 | $658.69 | 27 | Janssen Biotech, Inc. ($204.24) |
| 2017 | $659.04 | 24 | Endo Pharmaceuticals Inc. ($198.59) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Urology Gynecology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: HORMONE THERAPY | ||||||
| 09/04/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Medical Urology | ||||||
| 08/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: UROLOGY | ||||||
| 07/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: Oncology | ||||||
| 06/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,509 | 5,728 | $928,337 | $229,611 |
| 2022 | 24 | 3,514 | 5,820 | $1.1M | $251,955 |
| 2021 | 37 | 3,945 | 6,681 | $1.2M | $282,897 |
| 2020 | 37 | 3,761 | 6,920 | $1.1M | $255,825 |
Total Patients
14,729
Total Services
25,149
Medicare Billing
$1.0M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 655 | 1,209 | $533,462 | $128,316 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 227 | 311 | $97,312 | $24,764 | 25.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 65 | 77 | $75,804 | $16,669 | 22.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 169 | 182 | $38,087 | $9,781 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $29,540 | $6,884 | 23.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 395 | 600 | $28,341 | $5,886 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $24,444 | $5,783 | 23.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 223 | 289 | $15,944 | $5,208 | 32.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 757 | 1,443 | $15,065 | $4,895 | 32.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 29 | 35 | $17,346 | $4,362 | 25.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 17 | 17 | $15,599 | $3,675 | 23.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 296 | 406 | $3,654 | $3,402 | 93.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 186 | 308 | $7,457 | $2,436 | 32.7% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 79 | 236 | $6,124 | $2,000 | 32.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 32 | $6,324 | $1,733 | 27.4% |
| 87088 | Bacterial urine culture | Office | 2023 | 86 | 140 | $3,398 | $1,110 | 32.7% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 86 | 140 | $3,394 | $1,109 | 32.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 24 | $2,895 | $760.61 | 26.3% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 16 | 20 | $1,103 | $360.40 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 21 | $1,028 | $261.82 | 25.5% |
| 87185 | Detection of antimicrobial drug (antibiotic, antifungal, antiviral) | Office | 2023 | 30 | 33 | $470.25 | $153.45 | 32.6% |
| J0278 | Injection, amikacin sulfate, 100 mg | Office | 2023 | 18 | 92 | $1,546 | $60.53 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 689 | 1,275 | $595,739 | $138,866 | 23.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 89 | 115 | $133,481 | $27,425 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 300 | $99,198 | $22,838 | 23.0% |
About Dr. Lawrence Sigler, MD
Dr. Lawrence Sigler, MD is a Urology healthcare provider based in Bronxville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063581874.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Sigler, MD has received a total of $5,306 in payments from pharmaceutical and medical device companies, with $723.99 received in 2024. These payments were reported across 220 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,122).
As a Medicare-enrolled provider, Sigler has provided services to 14,729 Medicare beneficiaries, totaling 25,149 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Bronxville, NY
- Active Since 11/07/2006
- Last Updated 04/26/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1063581874
Products in Payments
- ERLEADA (Drug) $664.30
- GEMTESA (Drug) $562.45
- Erleada (Drug) $554.18
- Nubeqa (Drug) $435.66
- XIAFLEX (Biological) $322.64
- XTANDI (Drug) $310.84
- PROVENGE (Drug) $212.88
- Androgel (Drug) $173.09
- Xofigo (Drug) $172.11
- MYRBETRIQ (Drug) $154.64
- AQUABEAM ROBOTIC SYSTEM (Device) $150.00
- Xtandi (Drug) $129.78
- ELIGARD (Drug) $107.48
- Myrbetriq (Drug) $103.16
- ORGOVYX (Drug) $97.81
- ZYTIGA (Drug) $91.57
- XYOSTED (Drug) $88.99
- NOCDURNA (Drug) $85.75
- Axumin (Drug) $84.27
- KEYTRUDA (Biological) $80.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.